You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclophosphamide

Showing 51 - 75 of 2,373
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • QH103 Cell Injection
  • +2 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Sep 21, 2023

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

Recruiting
  • Ependymoma
  • +3 more
  • Augusta, Georgia
    Augusta University, Georgia Cancer Center
Dec 16, 2022

GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)

Not yet recruiting
  • GATA2
  • Immunodeficiency
  • Mycophenolate Mofetil
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Cyclophosphamide
  • +8 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Hematologic Diseases
  • allogeneic γ9δ2 T Cells
  • +3 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 23, 2023

Lymphoma, Large B-Cell, Diffuse Trial (Cyclophosphamide, TLI, Fludarabine)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Cyclophosphamide
  • +2 more
  • (no location specified)
Aug 18, 2023

Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Jan 30, 2023

Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Jun 8, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Cyclophosphamide
  • anti-human T-lymphocyte immunoglobulin (ATLG)
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

DLBCL - Diffuse Large B Cell Lymphoma Trial in Toronto (Cyclophosphamide, TLI)

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Cyclophosphamide
  • TLI
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 19, 2023

Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

Active, not recruiting
  • Pancreatic Cancer
  • Cyclophosphamide
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 5, 2023

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Cyclophosphamide
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial (Toripalimab, Epirubicin, High Intensity Focused Ultrasoun)

Not yet recruiting
  • Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
Aug 5, 2022

Aneurysm, Behcet Syndrome, Vascular Type Trial in Beijing (tocilizumab, tofacitinib, cyclophosphamide)

Not yet recruiting
  • Aneurysm
  • Behcet Syndrome, Vascular Type
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 26, 2023

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022